Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Int J Mol Sci ; 23(9)2022 Apr 28.
Artigo em Inglês | MEDLINE | ID: mdl-35563308

RESUMO

We introduce a new family of fungal protease inhibitors with ß-trefoil fold from the mushroom Coprinopsis cinerea, named cocaprins, which inhibit both cysteine and aspartic proteases. Two cocaprin-encoding genes are differentially expressed in fungal tissues. One is highly transcribed in vegetative mycelium and the other in the stipes of mature fruiting bodies. Cocaprins are small proteins (15 kDa) with acidic isoelectric points that form dimers. The three-dimensional structure of cocaprin 1 showed similarity to fungal ß-trefoil lectins. Cocaprins inhibit plant C1 family cysteine proteases with Ki in the micromolar range, but do not inhibit the C13 family protease legumain, which distinguishes them from mycocypins. Cocaprins also inhibit the aspartic protease pepsin with Ki in the low micromolar range. Mutagenesis revealed that the ß2-ß3 loop is involved in the inhibition of cysteine proteases and that the inhibitory reactive sites for aspartic and cysteine proteases are located at different positions on the protein. Their biological function is thought to be the regulation of endogenous proteolytic activities or in defense against fungal antagonists. Cocaprins are the first characterized aspartic protease inhibitors with ß-trefoil fold from fungi, and demonstrate the incredible plasticity of loop functionalization in fungal proteins with ß-trefoil fold.


Assuntos
Agaricales , Ácido Aspártico Proteases , Cisteína Proteases , Lotus , Agaricales/química , Ácido Aspártico Endopeptidases , Ácido Aspártico Proteases/genética , Cisteína , Cisteína Proteases/genética , Lotus/metabolismo , Peptídeo Hidrolases/metabolismo , Inibidores de Proteases/química
2.
Cell Immunol ; 347: 103999, 2020 01.
Artigo em Inglês | MEDLINE | ID: mdl-31733823

RESUMO

We are currently living the advent of a new age for medicine in which basic research is being quickly translated into marketable drugs, and the widespread access to genomics data is allowing the design and implementation of personalized solutions to medical conditions. Non-human primates (NHP) have gained an essential role in drug discovery and safety testing due to their close phylogenetic relationship to humans. In this study, a collection of well characterized genes of the human immune system was used to define the orthology-based immunome in four NHP species, with carefully curated annotations available based on multi-tissue RNA-seq datasets. A broad variation in the frequency of expressed protein isoforms was observed between species. Finally, this analysis also revealed the lack of expression of at least four different chemokines in new-world primates. In addition, transcripts corresponding to four genes including interleukin 12 subunit alpha were expressed in humans but no other primate species analyzed. Access to the non-human primate immunome is available in http://www.fidic.org.co:90/proyecto/.


Assuntos
Quimiocinas/genética , Bases de Dados de Ácidos Nucleicos , Bases de Dados de Proteínas , Subunidade p35 da Interleucina-12/genética , Primatas/genética , Pesquisa Translacional Biomédica/métodos , Animais , Aotidae/genética , Callithrix/genética , Desenho de Fármacos , Descoberta de Drogas/métodos , Humanos , Sistema Imunitário , Macaca mulatta/genética , Modelos Animais , Pan troglodytes/genética , Isoformas de Proteínas/genética
3.
Appl Environ Microbiol ; 84(23)2018 12 01.
Artigo em Inglês | MEDLINE | ID: mdl-30242007

RESUMO

Resistance of fungi to predation is thought to be mediated by toxic metabolites and proteins. Many of these fungal defense effectors are highly abundant in the fruiting body and not produced in the vegetative mycelium. The defense function of fruiting body-specific proteins, however, including cytoplasmically localized lectins and antinutritional proteins such as biotin-binding proteins, is mainly based on toxicity assays using bacteria as a heterologous expression system, with bacterivorous/omnivorous model organisms as predators. Here, we present an ecologically more relevant experimental setup to assess the toxicity of potential fungal defense proteins towards the fungivorous, stylet-feeding nematodes Aphelenchus avenae and Bursaphelenchus okinawaensis As a heterologous expression host, we exploited the filamentous fungus Ashbya gossypii Using this new system, we assessed the toxicity of six previously characterized, cytoplasmically localized, potential defense proteins from fruiting bodies of different fungal phyla against the two fungivorous nematodes. We found that all of the tested proteins were toxic against both nematodes, albeit to various degrees. The toxicity of these proteins against both fungivorous and bacterivorous nematodes suggests that their targets have been conserved between the different feeding groups of nematodes and that bacterivorous nematodes are valid model organisms to assess the nematotoxicity of potential fungal defense proteins.IMPORTANCE Our results support the hypothesis that cytoplasmic proteins abundant in fungal fruiting bodies are involved in fungal resistance against predation. The toxicity of these proteins toward stylet-feeding nematodes, which are also capable of feeding on plants, and the abundance of these proteins in edible mushrooms, may open possible avenues for biological crop protection against parasitic nematodes, e.g., by expression of these proteins in crops.


Assuntos
Proteínas Fúngicas/toxicidade , Fungos/química , Tylenchida/efeitos dos fármacos , Animais , Comportamento Alimentar/efeitos dos fármacos , Carpóforos/química , Tylenchida/fisiologia
4.
Fungal Genet Biol ; 102: 49-62, 2017 05.
Artigo em Inglês | MEDLINE | ID: mdl-27475110

RESUMO

Biofilm formation on fungal hyphae and production of antifungal molecules are strategies of bacteria in their competition with fungi for nutrients. Since these strategies are often coordinated and under control of quorum sensing by the bacteria, interference with this bacterial communication system can be used as a counter-strategy by the fungi in this competition. Hydrolysis of N-acyl-homoserine lactones (HSL), a quorum sensing molecule used by Gram-negative bacteria, by fungal cultures has been demonstrated. However, the enzymes that are responsible for this activity, have not been identified. In this study, we identified and characterized two paralogous HSL hydrolyzing enzymes from the coprophilous fungus Coprinopsis cinerea. The C. cinerea HSL lactonases belong to the metallo-ß-lactamase family and show sequence homology to and a similar biochemical activity as the well characterized lactonase AiiA from Bacillus thuringiensis. We show that the fungal lactonases, similar to the bacterial enzymes, are kept intracellularly and act as a sink for the bacterial quorum sensing signals both in C. cinerea and in Saccharomyces cerevisiae expressing C. cinerea lactonases, due to the ability of these signal molecules to diffuse over the fungal cell wall and plasma membrane. The two isogenes coding for the C. cinerea HSL lactonases are arranged in the genome as a tandem repeat and expressed preferentially in vegetative mycelium. The occurrence of orthologous genes in genomes of other basidiomycetes appears to correlate with a saprotrophic lifestyle.


Assuntos
Hidrolases de Éster Carboxílico/metabolismo , Coprinus/enzimologia , Coprinus/metabolismo , Bactérias Gram-Negativas/metabolismo , Percepção de Quorum , Hidrolases de Éster Carboxílico/genética , Coprinus/classificação , Coprinus/genética , Bactérias Gram-Negativas/genética , Hidrólise , Filogenia , Homologia de Sequência do Ácido Nucleico
5.
Medicine (Baltimore) ; 98(11): e14879, 2019 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-30882696

RESUMO

RATIONALE: Nocardia species are not commonly referred as primary infectious entities but rather as opportunistic pathogens. Infectious cases of Nocardia spp. in immunocompetent individuals are rare. PATIENT CONCERNS: An immunocompetent 58-year-old patient presented with recurrent headaches. DIAGNOSIS: A brain abscess was found and surgically drained. Matrix-assisted laser desorption ionization-time-of-flight mass spectrometry and heat shock protein 65/16S-23S rRNA gene intergenic spacer genotyping from the sample revealed the etiological agent as Nocardia beijingensis. INTERVENTIONS: Meropenem/amikacin/Trimethoprim-sulfamethoxazole were administered. OUTCOMES: The infection persisted leading to the patient's death. LESSONS: Here we present the first case of N. beijingensis infection of the central nervous system in an immunocompetent patient from Latin America. Further inquiry is needed to establish whether this species is more virulent than other Nocardia isolates.


Assuntos
Abscesso Encefálico/diagnóstico , Nocardiose/complicações , Antibacterianos/uso terapêutico , Abscesso Encefálico/etiologia , Humanos , América Latina , Masculino , Meropeném/uso terapêutico , Pessoa de Meia-Idade , Nocardia/patogenicidade , Nocardiose/diagnóstico , Tomografia Computadorizada por Raios X/métodos , Combinação Trimetoprima e Sulfametoxazol/uso terapêutico
6.
Protein Sci ; 17(2): 342-51, 2008 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-18096644

RESUMO

The Rv2707 gene encoding a putative alanine- and leucine-rich protein was found to be present in all Mycobacterium tuberculosis complex strains (by PCR) and its transcription was shown by RT-PCR in all but M. bovis and M. microti. Antibodies raised against Rv2707 peptides specifically recognized the native protein by Western blot and were able to locate this protein on the M. tuberculosis membrane by immunoelectron microscopy. A549 and U937 cells lines were used in binding assays involving synthetic peptides covering the whole Rv2707 protein. High A549 cell-binding peptide 16083 (281 QEEWPAPATHAHRLGNWLKAY 300) was identified. Peptides 16072 (61 LFGPDTLPAIEKSALSTAHSY 80) and 16084 (301 RIGVGTTTYSSTAQHSAVAA 320) presented high specific binding to both A549 and U937 cells. Cross-linking assays revealed that peptide 16084 specifically bound to a 40-kDa and a 50-kDa U937 cell membrane protein. High activity binding peptides (HABPs) 16083 and 16084 were able to inhibit M. tuberculosis invasion of A549 cells. Our results suggest that these sequences could be part of the binding sites used by the bacillus for interacting with target cells, and thus represent good candidates to be tested in a future subunit-based, multiepitope, antituberculosis vaccine.


Assuntos
Proteínas de Bactérias/química , Proteínas de Bactérias/metabolismo , Mycobacterium tuberculosis/metabolismo , Fragmentos de Peptídeos/metabolismo , Sequência de Aminoácidos , Proteínas de Bactérias/ultraestrutura , Linhagem Celular Tumoral , Biologia Computacional , Humanos , Microscopia Imunoeletrônica , Dados de Sequência Molecular , Mycobacterium tuberculosis/química , Mycobacterium tuberculosis/patogenicidade , Fragmentos de Peptídeos/síntese química , Fragmentos de Peptídeos/farmacologia , Ligação Proteica , Células U937
7.
Biochem Biophys Res Commun ; 372(4): 935-40, 2008 Aug 08.
Artigo em Inglês | MEDLINE | ID: mdl-18539140

RESUMO

Identifying Mycobacterium tuberculosis membrane proteins involved in binding to and invasion of host cells is important in designing subunit-based anti-tuberculosis vaccines. The Rv2969c gene sequence was identified by PCR in M. tuberculosis complex strains, being transcribed in M. tuberculosis H37Rv, M. tuberculosis H37Ra, and M. bovis BCG. Rabbits immunized with synthetic peptides from highly specific conserved regions of this protein produced antibodies recognizing 27 and 29 kDa bands in M. tuberculosis lysate, which is consistent with the molecular weight of the Rv2969c gene product in M. tuberculosis H37Rv. Immunoelectron microscopy revealed the protein was localized on the bacillus surface. Four and three specific high activity binding peptides (HABPs) to the A549 alveolar epithelial and U937 monocyte cell lines were found, respectively. Two of the HABPs found inhibited M. tuberculosis invasion of A549 cells, suggesting that these peptides might be good candidates to be included in a multiepitopic, subunit-based anti-tuberculosis vaccine.


Assuntos
Proteínas de Bactérias/imunologia , Proteínas de Membrana/imunologia , Mycobacterium tuberculosis/imunologia , Vacinas contra a Tuberculose/imunologia , Sequência de Aminoácidos , Animais , Anticorpos Antibacterianos/imunologia , Proteínas de Bactérias/análise , Proteínas de Bactérias/genética , Linhagem Celular , Genes Bacterianos , Humanos , Proteínas de Membrana/análise , Proteínas de Membrana/genética , Microscopia Imunoeletrônica , Dados de Sequência Molecular , Mycobacterium tuberculosis/genética , Peptídeos/genética , Peptídeos/imunologia , Coelhos , Vacinas contra a Tuberculose/genética
8.
Front Biosci ; 13: 650-6, 2008 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-17981577

RESUMO

Current methods for evaluating mycobacterial invasion of target cells pose technical difficulties including a long turn-around time. Thus, new methodologies must be developed that allow rapid and reliable monitoring of host cell invasion. Here, the invasion of A549 cell line by SYBR safe-labeled Mycobacterium tuberculosis (M. tuberculosis) H37Rv was assessed by flow cytometry and was expressed as the percentage of cells infected by M. tuberculosis. Over a third of A549 cells were invaded by M. tuberculosis, two hours after infection. The specificity of the invasion was confirmed in assays using red blood cells as target cells and Escherichia coli as the non-invasive bacterial control. These findings show that invasion of pulmonary epithelial cells by M. tuberculosis can rapidly and quantitatively be assessed with a great sensitivity by flow cytometric detection of SYBR safe-labeled M. tuberculosis.


Assuntos
Células Epiteliais/microbiologia , Citometria de Fluxo/métodos , Mycobacterium tuberculosis/metabolismo , Mycobacterium tuberculosis/patogenicidade , Antituberculosos/farmacologia , Linhagem Celular Tumoral , Eritrócitos/microbiologia , Escherichia coli/metabolismo , Humanos , Cinética , Testes de Sensibilidade Microbiana , Microscopia de Fluorescência , Ligação Proteica
9.
FEBS J ; 274(24): 6352-64, 2007 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-18005255

RESUMO

The characterization of membrane proteins having no identified function in Mycobacterium tuberculosis is important for a better understanding of the biology of this pathogen. In this work, the biological activity of the Rv2560 protein was characterized and evaluated. Primers used in PCR and RT-PCR assays revealed that the gene encoding protein Rv2560 is present in M. tuberculosis complex strains, but transcribed in only some of them. Sera obtained from rabbits inoculated with polymer peptides from this protein recognized a 33 kDa band in the M. tuberculosis lysate and a membrane fraction corresponding to the predicted molecular mass (33.1 kDa) of this protein. Immunoelectron microscopy analysis found this protein on the mycobacterial membrane. Sixteen peptides covering its entire length were chemically synthesized and tested for their ability to bind to A549 and U937 cells. Peptide 11024 (121VVALSDRATTAYTNTSGVSS140) showed high specific binding to both cell types (dissociation constants of 380 and 800 nm, respectively, and positive receptor-ligand interaction cooperativity), whereas peptide 11033 (284LIGIPVAALIHVYTYRKLSGG304) displayed high binding activity to A549 cells only. Cross-linking assays showed the specific binding of peptide 11024 to a 54 kDa membrane protein on U937. Invasion inhibition assays, in the presence of shared high-activity binding peptide identified for U937 and A549 cells, presented maximum inhibition percentages of 50.53% and 58.27%, respectively. Our work highlights the relevance of the Rv2560 protein in the M. tuberculosis invasion process of monocytes and epithelial cells, and represents a fundamental step in the rational selection of new antigens to be included as components in a multiepitope, subunit-based, chemically synthesized, antituberculosis vaccine.


Assuntos
Proteínas de Bactérias/metabolismo , Proteínas de Membrana/metabolismo , Mycobacterium tuberculosis/metabolismo , Sequência de Aminoácidos , Animais , Proteínas de Bactérias/genética , Proteínas de Bactérias/imunologia , Western Blotting , Linhagem Celular Tumoral , Dicroísmo Circular , DNA Bacteriano/química , DNA Bacteriano/genética , DNA Bacteriano/isolamento & purificação , Citometria de Fluxo , Humanos , Soros Imunes/química , Soros Imunes/imunologia , Imunização , Proteínas de Membrana/genética , Proteínas de Membrana/imunologia , Microscopia Imunoeletrônica , Dados de Sequência Molecular , Mycobacterium tuberculosis/genética , Mycobacterium tuberculosis/ultraestrutura , Reação em Cadeia da Polimerase , Ligação Proteica , Coelhos , Análise de Sequência de DNA , Análise de Sequência de Proteína , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz , Células U937
10.
Vaccine ; 26(34): 4387-95, 2008 Aug 12.
Artigo em Inglês | MEDLINE | ID: mdl-18585422

RESUMO

This study reports the Rv1490 gene presence and transcription in members of the Mycobacterium tuberculosis complex, and characterises the encoded Rv1490 putative membrane protein in M. tuberculosis H37Rv. Rv1490 derived peptides were synthesised and their A549 and U937 cell binding ability was tested, finding five high activity binding peptides (HABPs) for A549 and five for U937. Only two HABPs (11060 and 11073) were shared by both cell lines, both of which affected M. tuberculosis' invading ability to target cells, thus indicating an important role for these sequences in M. tuberculosis entry to A549 alveolar epithelial cells and supporting their inclusion in further studies on the development of a subunit-based multi-epitopic, chemically synthesised anti-tuberculosis vaccine.


Assuntos
Proteínas de Bactérias/metabolismo , Células Epiteliais/microbiologia , Proteínas de Membrana/metabolismo , Mycobacterium tuberculosis/fisiologia , Peptídeos/metabolismo , Sequência de Aminoácidos , Animais , Aderência Bacteriana , Proteínas de Bactérias/genética , Linhagem Celular , Proteínas de Membrana/genética , Microscopia Eletrônica de Transmissão , Dados de Sequência Molecular , Mycobacterium tuberculosis/genética , Peptídeos/genética , Ligação Proteica , Coelhos
11.
J Immunotoxicol ; 4(4): 279-85, 2007 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-18958738

RESUMO

Evaluating immunomodulating effects is currently a fundamental parameter when designing pharmaceutical products. Rather than wait for the appearance of immunotoxic effects in patients, pre-clinical assays that characterize these potential events in experimental models not only can facilitate the understanding of how these phenomena arise, but sometimes reveal findings that can lead to modifications in currently-accepted methodologies used for estimating the pre-clinical assay predictive risk values. Pentamidine isethionate, a drug used as a second option in treating leishmaniasis, has been repeatedly shown in animals and humans to exert a toxicity at the renal, cardiac and hepatic level; however, its immunotoxic effect have not been as fully evaluated. The potential immunomodulatory effects of pentamidine on splenocytes from two species of mice (BALB/c and ICR) were evaluated ex vivo in this study. The results here indicated that there were significant differences in subpopulation profiles between the strains even before treatment with the drug, with the variances most apparent regarding the relative percentages of CD8(+) and CD19(+) cells in splenocyte preparations. The data also showed that the drug preferentially induced toxicity in BALB/c mice CD8(+) and CD19(+) cells more so than in their ICR counterparts. Conversely, the ICR cells seemed to be more susceptible to drug-induced spontaneous blastogenesis than the cells from BALB/c hosts. The differential results seen here confirm that: any potential immunomodulatory effect of a drug should be studied in at least two different mouse strains during an evaluation of overall toxicologic potential; and, there should be attempts to correlate phenotypical findings with those of functionality before a drug can truly be deemed a safe compound.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA